Interplay between negative symptoms, time spent doing nothing, and negative emotions in patients with schizophrenia spectrum disorders: results from a 37-site study.


Journal

Schizophrenia (Heidelberg, Germany)
ISSN: 2754-6993
Titre abrégé: Schizophrenia (Heidelb)
Pays: Germany
ID NLM: 9918367987006676

Informations de publication

Date de publication:
21 Sep 2023
Historique:
received: 21 03 2023
accepted: 26 06 2023
medline: 22 9 2023
pubmed: 22 9 2023
entrez: 21 9 2023
Statut: epublish

Résumé

This study evaluated the relationship between negative symptoms, daily time use (productive/non-productive activities, PA/NPA), and negative emotions in schizophrenia-spectrum disorders (SSDs): 618 individuals with SSDs (311 residential care patients [RCPs], 307 outpatients) were surveyed about socio-demographic, clinical (BPRS, BNSS) and daily time use (paper-and-pencil Time Use Survey completed twice/week) characteristics. Among them 57 RCPs and 46 outpatients, matched to 112 healthy controls, also underwent ecological monitoring of emotions (8 times/day for a week) through Experience Sampling Method (ESM). RCPs spent significantly less time in PA than outpatients. Patients with more negative symptomatology spent more time in NPA and less in PA compared to patients with milder symptoms. Higher time spent in NPA was associated with negative emotions (p < 0.001 during workdays) even when correcting for BNSS total and antipsychotic polypharmacy (p = 0.002 for workdays, p = 0.006 for Sundays). Future studies are needed to explore in more detail the relationship between negative emotions, negative symptoms, time use, and functioning in individuals with SSDs, providing opportunities for more informed and personalised clinical treatment planning and research into interactions between different motivational, saliency and behavioural aspects in individuals with SSDs.

Identifiants

pubmed: 37735175
doi: 10.1038/s41537-023-00372-x
pii: 10.1038/s41537-023-00372-x
pmc: PMC10514038
doi:

Types de publication

Journal Article

Langues

eng

Pagination

63

Subventions

Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : RF-2018-12365514
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : RF-2018-12365514
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : RF-2018-12365514
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : RF-2018-12365514
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : RF-2018-12365514
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : RF-2018-12365514
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : RF-2018-12365514
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : RF-2018-12365514
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : RF-2018-12365514
Organisme : Ministero della Salute (Ministry of Health, Italy)
ID : RF-2018-12365514

Investigateurs

Stefano Barlati (S)
Andrea Baroncelli (A)
Filippo Besana (F)
Maria Elena Boero (ME)
Massimo Clerici (M)
Vittorio Di Michele (V)
Federico Durbano (F)
Maria Gabriella Foia (MG)
Stefania Impicci (S)
Filippo Maria Jacoponi (FM)
Emanuela Leuci (E)
Daniela Malagamba (D)
Marina Marina (M)
Alessandra Martinelli (A)
Emiliano Monzani (E)
Gaetano Nappi (G)
Benedetto Piccicacchi (B)
Roberto Placenti (R)
Arturo Rippa (A)
Giambattista Tura (G)
Salvatore Zizolfi (S)

Informations de copyright

© 2023. Springer Nature Limited.

Références

Br J Psychiatry. 2003 Jul;183:50-6
pubmed: 12835244
Arch Gen Psychiatry. 1982 Jul;39(7):784-8
pubmed: 7165477
Can J Psychiatry. 2005 Apr;50(5):247-57
pubmed: 15968839
Schizophr Bull. 2010 Mar;36(2):359-69
pubmed: 18644851
Schizophr Res. 2010 Sep;122(1-3):156-63
pubmed: 20051314
Psychiatry Res. 2015 Dec 30;230(3):860-6
pubmed: 26626950
Schizophr Res. 2017 May;183:49-55
pubmed: 27881233
Curr Opin Psychiatry. 2018 May;31(3):246-255
pubmed: 29474266
Psychiatr Serv. 2019 Apr 1;70(4):302-308
pubmed: 30717644
Psychol Med. 2023 Mar;53(4):1565-1575
pubmed: 34420532
Schizophr Res. 2006 Sep;86(1-3):181-8
pubmed: 16857346
CNS Spectr. 2014 Dec;19 Suppl 1:38-52; quiz 35-7, 53
pubmed: 25403863
J Psychiatr Res. 2022 Nov;155:313-319
pubmed: 36174366
Psychol Med. 2018 Dec;48(16):2776-2785
pubmed: 29501072
Neuropsychiatr Dis Treat. 2020 Feb 21;16:519-534
pubmed: 32110026
Am J Psychiatry. 2012 Apr;169(4):364-73
pubmed: 22407079
Nat Rev Endocrinol. 2011 Oct 18;8(2):114-26
pubmed: 22009159
Eur Psychiatry. 2015 Jul;30(5):641-7
pubmed: 25758156
Acta Psychiatr Scand. 2012 May;125(5):352-62
pubmed: 22176559
Eur Psychiatry. 2021 Mar 17;64(1):e21
pubmed: 33726883
Appetite. 2019 Jan 1;132:208-221
pubmed: 30217475
Am J Psychiatry. 2023 May 1;180(5):367-376
pubmed: 36891649
BMC Psychiatry. 2020 Jun 8;20(1):287
pubmed: 32513140
Br J Psychiatry. 2016 Jul;209(1):48-53
pubmed: 26585094
Schizophr Res. 2016 Jan;170(1):191-7
pubmed: 26673972
World Psychiatry. 2017 Feb;16(1):14-24
pubmed: 28127915
Occup Ther Int. 2004;11(3):177-91
pubmed: 15297897
Clin Psychol Psychother. 2020 Mar;27(2):107-135
pubmed: 31661593
Schizophr Res. 2012 Jun;138(1):18-28
pubmed: 22534420
Schizophr Bull. 2007 Jul;33(4):1013-22
pubmed: 17099070
Eur Psychiatry. 2018 Oct;54:124-144
pubmed: 30257806
Schizophr Bull. 1996;22(4):659-69
pubmed: 8938920
J Nerv Ment Dis. 1987 Sep;175(9):526-36
pubmed: 3655778
Psychiatr Rehabil J. 2011 Winter;34(3):243-7
pubmed: 21208863
Occup Ther Int. 2006;13(2):100-21
pubmed: 16862959
Psychol Med. 2020 Sep;50(12):1949-1965
pubmed: 32684198
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Acta Psychiatr Scand. 2018 May;137(5):380-390
pubmed: 29532909
Scand J Occup Ther. 2014;21 Suppl 1:53-63
pubmed: 25116746
Schizophr Bull. 2018 Oct 17;44(6):1195-1203
pubmed: 29762765
Schizophr Res. 2012 Dec;142(1-3):88-92
pubmed: 23127378
Schizophr Res. 2016 Jan;170(1):198-204
pubmed: 26701649
Schizophr Bull. 2020 Feb 26;46(2):242-251
pubmed: 31504955
Schizophr Res. 2017 Aug;186:29-38
pubmed: 27230288
World Psychiatry. 2022 Jun;21(2):248-271
pubmed: 35524619
J Clin Psychiatry. 2010 Mar;71(3):280-6
pubmed: 19895779
Dialogues Clin Neurosci. 2006;8(1):59-70
pubmed: 16640115
Schizophr Res. 2016 Oct;176(2-3):480-484
pubmed: 27422333
Psychiatry Res. 2021 Jun;300:113924
pubmed: 33848963
Schizophr Res. 2020 Aug;222:429-436
pubmed: 32389616
J Psychiatr Res. 2014 Jun;53:141-8
pubmed: 24561000
Schizophr Res. 2015 Jun;165(1):76-82
pubmed: 25868935

Auteurs

Giulio D'Anna (G)

Department of Mental Health, AUSL Toscana Centro, Prato, Italy.

Cristina Zarbo (C)

Department of Psychology, University of Milano Bicocca, Milan, Italy.

Giuseppe Cardamone (G)

Department of Mental Health, AUSL Toscana Centro, Prato, Italy.

Manuel Zamparini (M)

Unit of Epidemiological and Evaluation Psychiatry, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Stefano Calza (S)

Unit of Biostatistics and Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. stefano.calza@unibs.it.

Matteo Rota (M)

Unit of Biostatistics and Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Christoph U Correll (CU)

Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany.

Matteo Rocchetti (M)

Department of Mental Health and Dependence, ASST of Pavia, Pavia, Italy.

Fabrizio Starace (F)

Department of Mental Health and Pathological Addiction, AUSL di Modena, Modena, Italy.

Giovanni de Girolamo (G)

Unit of Epidemiological and Evaluation Psychiatry, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. gdegirolamo@fatebenefratelli.eu.

Classifications MeSH